Drug Profile
IMD 2560
Alternative Names: IMD-2560Latest Information Update: 28 May 2013
Price :
$50
*
At a glance
- Originator Institute of Medicinal Molecular Design
- Class Anti-inflammatories
- Mechanism of Action I-kappa B kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Osteoporosis; Rheumatoid arthritis
Most Recent Events
- 28 May 2013 IMD 2560 is available for licensing as of 28 May 2013. http://www.immd.co.jp